Outcomes and Differences by Occluded Vessel after Endovascular Thrombectomy for Isolated Medium Vessel Occlusions
Main Author: | |
---|---|
Publication Date: | 2024 |
Other Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | eng |
Source: | Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
Download full: | http://hdl.handle.net/10400.17/5061 |
Summary: | Background: The outcomes of endovascular thrombectomy (EVT) for medium vessel occlusions (MeVOs) of specific vascular territories remain unknown. We aimed to investigate EVT outcomes by MeVO locations using the data from an ongoing international multicenter registry. Methods: Patients with isolated MeVO who underwent EVT between January 2013 and December 2022 were retrospectively analyzed. Isolated MeVO was defined as an occlusion of the A2 or A3 (A2/A3), M2 or M3, and P2 or P3 (P2/P3). Outcomes included a 90-day modified Rankin score (mRS) of 0-2, successful recanalization (modified Thrombolysis in Cerebral Infarction score ≥ 2b), early neurological deterioration (END) or improvement (ENI), and 90-day mortality. END was defined as a worsening of ≥4 points from the baseline National Institutes of Health Stroke Scale (NIHSS) score within 24 h of EVT, while ENI was defined as an improvement of ≥4 points from the baseline NIHSS score within 24 h of EVT. Results: 1744 MeVOs included. Compared to M2 occlusions (n = 1542, 88.4%), A2/A3 (n = 36, 2.1%) occlusions had lower odds of 90-day mRS 0-2 (adjusted odds ratio [aOR] 0.30, 95% confidence interval [CI] 0.11-0.80), and P2/P3 occlusions (n = 49, 2.8%) had lower odds of successful recanalization (aOR 0.19, 95% CI 0.07-0.50), and higher odds of END (aOR 3.53, 95% CI 1.35-9.25). Other outcomes showed no significant differences. Conclusions: A2/A3 occlusions were more likely to have worse outcomes compared to M2 occlusions after EVT for patients with isolated MeVOs. |
id |
RCAP_ec835ccf7cc89241141624bb18864dda |
---|---|
oai_identifier_str |
oai:repositorio.chlc.pt:10400.17/5061 |
network_acronym_str |
RCAP |
network_name_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
repository_id_str |
https://opendoar.ac.uk/repository/7160 |
spelling |
Outcomes and Differences by Occluded Vessel after Endovascular Thrombectomy for Isolated Medium Vessel OcclusionsAged80 and overFemaleMaleHumansEndovascular Procedures* / methodsMiddle AgedRegistriesRetrospective StudiesThrombectomy* / methodsBackground: The outcomes of endovascular thrombectomy (EVT) for medium vessel occlusions (MeVOs) of specific vascular territories remain unknown. We aimed to investigate EVT outcomes by MeVO locations using the data from an ongoing international multicenter registry. Methods: Patients with isolated MeVO who underwent EVT between January 2013 and December 2022 were retrospectively analyzed. Isolated MeVO was defined as an occlusion of the A2 or A3 (A2/A3), M2 or M3, and P2 or P3 (P2/P3). Outcomes included a 90-day modified Rankin score (mRS) of 0-2, successful recanalization (modified Thrombolysis in Cerebral Infarction score ≥ 2b), early neurological deterioration (END) or improvement (ENI), and 90-day mortality. END was defined as a worsening of ≥4 points from the baseline National Institutes of Health Stroke Scale (NIHSS) score within 24 h of EVT, while ENI was defined as an improvement of ≥4 points from the baseline NIHSS score within 24 h of EVT. Results: 1744 MeVOs included. Compared to M2 occlusions (n = 1542, 88.4%), A2/A3 (n = 36, 2.1%) occlusions had lower odds of 90-day mRS 0-2 (adjusted odds ratio [aOR] 0.30, 95% confidence interval [CI] 0.11-0.80), and P2/P3 occlusions (n = 49, 2.8%) had lower odds of successful recanalization (aOR 0.19, 95% CI 0.07-0.50), and higher odds of END (aOR 3.53, 95% CI 1.35-9.25). Other outcomes showed no significant differences. Conclusions: A2/A3 occlusions were more likely to have worse outcomes compared to M2 occlusions after EVT for patients with isolated MeVOs.ElsevierElsevierRepositório da Unidade Local de Saúde São JoséMatsukawa, HidetoshiUchida, KazutakaCunningham, ConorSowlat, Mohammad-MahdiElawady, Sameh SamirMaier, IlkoJabbour, PascalKim, Joon-TaeWolfe, Stacey QuinteroRai, AnsaarStarke, RobertPsychogios, Marios-NikosShaban, AmirArthur, AdamCuellar, HugoHoward, BrianAlawieh, AliRomano, DanieleTanweer, OmarMascitelli, JustinFragata, IsabelPolifka, AdamOsbun, JoshuaCrosa, RobertoMatouk, CharlesPark, MinBrinjikji, WaleedMoss, MarkWilliamson, RichardNavia, PedroKan, PeterLeacy, ReadeChowdhry, ShakeelEzzeldin, MohamadSpiotta, AlejandroLevitt, MichaelYoshimura, ShinichiStroke Thrombectomy and Aneurysm Registry (STAR) Collaborators2025-02-14T16:18:19Z2024-072024-07-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/5061eng0022-510X10.1016/j.jns.2024.123054info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-03-06T16:50:59Zoai:repositorio.chlc.pt:10400.17/5061Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-29T00:21:43.158416Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse |
dc.title.none.fl_str_mv |
Outcomes and Differences by Occluded Vessel after Endovascular Thrombectomy for Isolated Medium Vessel Occlusions |
title |
Outcomes and Differences by Occluded Vessel after Endovascular Thrombectomy for Isolated Medium Vessel Occlusions |
spellingShingle |
Outcomes and Differences by Occluded Vessel after Endovascular Thrombectomy for Isolated Medium Vessel Occlusions Matsukawa, Hidetoshi Aged 80 and over Female Male Humans Endovascular Procedures* / methods Middle Aged Registries Retrospective Studies Thrombectomy* / methods |
title_short |
Outcomes and Differences by Occluded Vessel after Endovascular Thrombectomy for Isolated Medium Vessel Occlusions |
title_full |
Outcomes and Differences by Occluded Vessel after Endovascular Thrombectomy for Isolated Medium Vessel Occlusions |
title_fullStr |
Outcomes and Differences by Occluded Vessel after Endovascular Thrombectomy for Isolated Medium Vessel Occlusions |
title_full_unstemmed |
Outcomes and Differences by Occluded Vessel after Endovascular Thrombectomy for Isolated Medium Vessel Occlusions |
title_sort |
Outcomes and Differences by Occluded Vessel after Endovascular Thrombectomy for Isolated Medium Vessel Occlusions |
author |
Matsukawa, Hidetoshi |
author_facet |
Matsukawa, Hidetoshi Uchida, Kazutaka Cunningham, Conor Sowlat, Mohammad-Mahdi Elawady, Sameh Samir Maier, Ilko Jabbour, Pascal Kim, Joon-Tae Wolfe, Stacey Quintero Rai, Ansaar Starke, Robert Psychogios, Marios-Nikos Shaban, Amir Arthur, Adam Cuellar, Hugo Howard, Brian Alawieh, Ali Romano, Daniele Tanweer, Omar Mascitelli, Justin Fragata, Isabel Polifka, Adam Osbun, Joshua Crosa, Roberto Matouk, Charles Park, Min Brinjikji, Waleed Moss, Mark Williamson, Richard Navia, Pedro Kan, Peter Leacy, Reade Chowdhry, Shakeel Ezzeldin, Mohamad Spiotta, Alejandro Levitt, Michael Yoshimura, Shinichi Stroke Thrombectomy and Aneurysm Registry (STAR) Collaborators |
author_role |
author |
author2 |
Uchida, Kazutaka Cunningham, Conor Sowlat, Mohammad-Mahdi Elawady, Sameh Samir Maier, Ilko Jabbour, Pascal Kim, Joon-Tae Wolfe, Stacey Quintero Rai, Ansaar Starke, Robert Psychogios, Marios-Nikos Shaban, Amir Arthur, Adam Cuellar, Hugo Howard, Brian Alawieh, Ali Romano, Daniele Tanweer, Omar Mascitelli, Justin Fragata, Isabel Polifka, Adam Osbun, Joshua Crosa, Roberto Matouk, Charles Park, Min Brinjikji, Waleed Moss, Mark Williamson, Richard Navia, Pedro Kan, Peter Leacy, Reade Chowdhry, Shakeel Ezzeldin, Mohamad Spiotta, Alejandro Levitt, Michael Yoshimura, Shinichi Stroke Thrombectomy and Aneurysm Registry (STAR) Collaborators |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Elsevier Repositório da Unidade Local de Saúde São José |
dc.contributor.author.fl_str_mv |
Matsukawa, Hidetoshi Uchida, Kazutaka Cunningham, Conor Sowlat, Mohammad-Mahdi Elawady, Sameh Samir Maier, Ilko Jabbour, Pascal Kim, Joon-Tae Wolfe, Stacey Quintero Rai, Ansaar Starke, Robert Psychogios, Marios-Nikos Shaban, Amir Arthur, Adam Cuellar, Hugo Howard, Brian Alawieh, Ali Romano, Daniele Tanweer, Omar Mascitelli, Justin Fragata, Isabel Polifka, Adam Osbun, Joshua Crosa, Roberto Matouk, Charles Park, Min Brinjikji, Waleed Moss, Mark Williamson, Richard Navia, Pedro Kan, Peter Leacy, Reade Chowdhry, Shakeel Ezzeldin, Mohamad Spiotta, Alejandro Levitt, Michael Yoshimura, Shinichi Stroke Thrombectomy and Aneurysm Registry (STAR) Collaborators |
dc.subject.por.fl_str_mv |
Aged 80 and over Female Male Humans Endovascular Procedures* / methods Middle Aged Registries Retrospective Studies Thrombectomy* / methods |
topic |
Aged 80 and over Female Male Humans Endovascular Procedures* / methods Middle Aged Registries Retrospective Studies Thrombectomy* / methods |
description |
Background: The outcomes of endovascular thrombectomy (EVT) for medium vessel occlusions (MeVOs) of specific vascular territories remain unknown. We aimed to investigate EVT outcomes by MeVO locations using the data from an ongoing international multicenter registry. Methods: Patients with isolated MeVO who underwent EVT between January 2013 and December 2022 were retrospectively analyzed. Isolated MeVO was defined as an occlusion of the A2 or A3 (A2/A3), M2 or M3, and P2 or P3 (P2/P3). Outcomes included a 90-day modified Rankin score (mRS) of 0-2, successful recanalization (modified Thrombolysis in Cerebral Infarction score ≥ 2b), early neurological deterioration (END) or improvement (ENI), and 90-day mortality. END was defined as a worsening of ≥4 points from the baseline National Institutes of Health Stroke Scale (NIHSS) score within 24 h of EVT, while ENI was defined as an improvement of ≥4 points from the baseline NIHSS score within 24 h of EVT. Results: 1744 MeVOs included. Compared to M2 occlusions (n = 1542, 88.4%), A2/A3 (n = 36, 2.1%) occlusions had lower odds of 90-day mRS 0-2 (adjusted odds ratio [aOR] 0.30, 95% confidence interval [CI] 0.11-0.80), and P2/P3 occlusions (n = 49, 2.8%) had lower odds of successful recanalization (aOR 0.19, 95% CI 0.07-0.50), and higher odds of END (aOR 3.53, 95% CI 1.35-9.25). Other outcomes showed no significant differences. Conclusions: A2/A3 occlusions were more likely to have worse outcomes compared to M2 occlusions after EVT for patients with isolated MeVOs. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-07 2024-07-01T00:00:00Z 2025-02-14T16:18:19Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.17/5061 |
url |
http://hdl.handle.net/10400.17/5061 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
0022-510X 10.1016/j.jns.2024.123054 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier |
publisher.none.fl_str_mv |
Elsevier |
dc.source.none.fl_str_mv |
reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia instacron:RCAAP |
instname_str |
FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
collection |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
repository.name.fl_str_mv |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
repository.mail.fl_str_mv |
info@rcaap.pt |
_version_ |
1833600503473242112 |